CA2099117A1 - Sels d'un derive de la 4-amino-3-acylquinoline et leur utilisation comme inhibiteurs de la secretion acide gastrique - Google Patents

Sels d'un derive de la 4-amino-3-acylquinoline et leur utilisation comme inhibiteurs de la secretion acide gastrique

Info

Publication number
CA2099117A1
CA2099117A1 CA002099117A CA2099117A CA2099117A1 CA 2099117 A1 CA2099117 A1 CA 2099117A1 CA 002099117 A CA002099117 A CA 002099117A CA 2099117 A CA2099117 A CA 2099117A CA 2099117 A1 CA2099117 A1 CA 2099117A1
Authority
CA
Canada
Prior art keywords
salts
inhibitors
amino
salt
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002099117A
Other languages
English (en)
Inventor
Robert John Ife
Colin Andrew Leach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Intercredit BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919101919A external-priority patent/GB9101919D0/en
Priority claimed from GB919101918A external-priority patent/GB9101918D0/en
Application filed by Individual filed Critical Individual
Publication of CA2099117A1 publication Critical patent/CA2099117A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
CA002099117A 1991-01-29 1992-01-27 Sels d'un derive de la 4-amino-3-acylquinoline et leur utilisation comme inhibiteurs de la secretion acide gastrique Abandoned CA2099117A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919101919A GB9101919D0 (en) 1991-01-29 1991-01-29 Compound
GB9101919.0 1991-01-29
GB9101918.2 1991-01-29
GB919101918A GB9101918D0 (en) 1991-01-29 1991-01-29 Compound

Publications (1)

Publication Number Publication Date
CA2099117A1 true CA2099117A1 (fr) 1992-07-30

Family

ID=26298350

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002099117A Abandoned CA2099117A1 (fr) 1991-01-29 1992-01-27 Sels d'un derive de la 4-amino-3-acylquinoline et leur utilisation comme inhibiteurs de la secretion acide gastrique

Country Status (18)

Country Link
EP (1) EP0569396A1 (fr)
JP (1) JPH06504541A (fr)
CN (1) CN1064268A (fr)
AP (1) AP337A (fr)
AU (1) AU652028B2 (fr)
CA (1) CA2099117A1 (fr)
CZ (1) CZ153293A3 (fr)
FI (1) FI933376L (fr)
HU (1) HUT67609A (fr)
IE (1) IE920267A1 (fr)
IL (1) IL100791A0 (fr)
MA (1) MA22401A1 (fr)
MX (1) MX9200338A (fr)
NO (1) NO932722D0 (fr)
NZ (1) NZ241408A (fr)
PT (1) PT100056A (fr)
SK (1) SK70993A3 (fr)
WO (1) WO1992012969A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
WO2005041961A1 (fr) 2003-11-03 2005-05-12 Astrazeneca Ab Procede d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds

Also Published As

Publication number Publication date
AU1179992A (en) 1992-08-27
SK70993A3 (en) 1994-01-12
EP0569396A1 (fr) 1993-11-18
NO932722L (no) 1993-07-28
IL100791A0 (en) 1992-09-06
AP9200352A0 (en) 1992-01-31
NO932722D0 (no) 1993-07-28
FI933376A7 (fi) 1993-07-28
NZ241408A (en) 1994-05-26
IE920267A1 (en) 1992-07-29
AU652028B2 (en) 1994-08-11
CZ153293A3 (en) 1993-12-15
CN1064268A (zh) 1992-09-09
MX9200338A (es) 1992-12-01
WO1992012969A1 (fr) 1992-08-06
MA22401A1 (fr) 1992-10-01
JPH06504541A (ja) 1994-05-26
FI933376A0 (fi) 1993-07-28
HU9302201D0 (en) 1993-10-28
HUT67609A (en) 1995-04-28
AP337A (en) 1994-04-08
FI933376L (fi) 1993-07-28
PT100056A (pt) 1993-03-31

Similar Documents

Publication Publication Date Title
JP4045070B2 (ja) キノリン誘導体
KR100704152B1 (ko) ＮＦ-κＢ 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제
JPH08268890A (ja) Ｃ型肝炎の予防・治療剤
JP2003512454A (ja) 悪性腫瘍治療薬
JP2002513006A (ja) キノリン誘導体
AP337A (en) Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion.
JP2672101B2 (ja) キサンテノン−４−酢酸誘導体
JP2502343B2 (ja) 薬学的に活性な置換ベンズアミド
CN1226236A (zh) 新化合物
WO1997032863A1 (fr) Derives de thiazolidine-2,4-dione
JPH0430924B2 (fr)
EP1097924B1 (fr) Dérivés de la 4-hydroxy-4-phenylpiperidine ayant une activité agoniste opioide et médicaments les contenant
RU2236407C2 (ru) Производные пиримидина
JP2974351B2 (ja) プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート
US4252818A (en) Novel benzopyran derivatives
GB2024011A (en) Use of arylamino benzoic acids as hypoglycemic agents and pharmaceutical compositions for said use
GB2193210A (en) Glycine derivatives
KR20010022833A (ko) 2-｛3-[4-(2-ｔ-부틸-6-트리플루오로메틸피리미딘-4-일)피페라진-1-일]프로필머캅토｝피리미딘-4-올-푸마레이트
EP0308059B1 (fr) 1,2,3,4-Tétrahydroisoquinoléines en tant qu'agents antiarhythmiques
JPH069402A (ja) 抗潰瘍剤
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
HU183555B (en) Process for preparing n-/1-allyl-2-pyrrolidinyl-methyl/-2-methoxy-4-amino-5-methyl-sulphamoyl-benzamide
EP1749817A1 (fr) Composition d"agent de contrôle de douleurs neurogènes
JPH0517442A (ja) ピペリジン誘導体
JPS6350327B2 (fr)

Legal Events

Date Code Title Description
FZDE Discontinued